Olivera Story Jovanova,Ivana Nedeljkovic,Derek Spieler,Rosie M Walker,Chunyu Liu,Michelle Luciano,Jan Bressler,Jennifer Brody,Amanda J Drake,Kathryn L Evans,Rahul Gondalia,Sonja Kunze,Brigitte Kuhnel,Jari Lahti,Rozenn N Lemaitre,Riccardo E Marioni,Brenton Swenson,Jayandra Jung Himali,Hongsheng Wu,Yun Li,Allan F McRae,Tom C Russ,James Stewart,Zhiying Wang,Guosheng Zhang,Karl-Heinz Ladwig,Andre G Uitterlinden,Xiuqing Guo,Annette Peters,Katri Räikkönen,John M Starr,Melanie Waldenberger,Naomi R Wray,Eric A Whitsel,Nona Sotoodehnia,Sudha Seshadri,David J Porteous,Joyce van Meurs,Thomas H Mosley,Andrew M McIntosh,Michael M Mendelson,Daniel Levy,Lifang Hou,Johan G Eriksson,Myriam Fornage,Ian J Deary,Andrea Baccarelli,Henning Tiemeier,Najaf Amin

Abstract:Importance: Depressive disorders arise from a combination of genetic and environmental risk factors. Epigenetic disruption provides a plausible mechanism through which gene-environment interactions lead to depression. Large-scale, epigenome-wide studies on depression are missing, hampering the identification of potentially modifiable biomarkers. Objective: To identify epigenetic mechanisms underlying depression in middle-aged and elderly persons, using DNA methylation in blood. Design, setting, and participants: To date, the first cross-ethnic meta-analysis of epigenome-wide association studies (EWAS) within the framework of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium was conducted. The discovery EWAS included 7948 individuals of European origin from 9 population-based cohorts. Participants who were assessed for both depressive symptoms and whole-blood DNA methylation were included in the study. Results of EWAS were pooled using sample-size weighted meta-analysis. Replication of the top epigenetic sites was performed in 3308 individuals of African American and European origin from 2 population-based cohorts. Main outcomes and measures: Whole-blood DNA methylation levels were assayed with Illumina-Infinium Human Methylation 450K BeadChip and depressive symptoms were assessed by questionnaire. Results: The discovery cohorts consisted of 7948 individuals (4104 [51.6%] women) with a mean (SD) age of 65.4 (5.8) years. The replication cohort consisted of 3308 individuals (2456 [74.2%] women) with a mean (SD) age of 60.3 (6.4) years. The EWAS identified methylation of 3 CpG sites to be significantly associated with increased depressive symptoms: cg04987734 (P = 1.57 × 10-08; n = 11 256; CDC42BPB gene), cg12325605 (P = 5.24 × 10-09; n = 11 256; ARHGEF3 gene), and an intergenic CpG site cg14023999 (P = 5.99 × 10-08; n = 11 256; chromosome = 15q26.1). The predicted expression of the CDC42BPB gene in the brain (basal ganglia) (effect, 0.14; P = 2.7 × 10-03) and of ARHGEF3 in fibroblasts (effect, -0.48; P = 9.8 × 10-04) was associated with major depression. Conclusions and relevance: This study identifies 3 methylated sites associated with depressive symptoms. All 3 findings point toward axon guidance as the common disrupted pathway in depression. The findings provide new insights into the molecular mechanisms underlying the complex pathophysiology of depression. Further research is warranted to determine the utility of these findings as biomarkers of depression and evaluate any potential role in the pathophysiology of depression and their downstream clinical effects.

Epigenetic and Structural Brain Aging and their Associations with Major Depressive Disorder and Inflammatory Markers

Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder

Epigenetic Age Analysis of Brain in Major Depressive Disorder.

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group

DNA Methylation Age Acceleration Mediates the Relationship between Systemic Inflammation and Cognitive Impairment

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes

Older molecular brain age in severe mental illness

Unraveling the association between major depressive disorder and senescent biomarkers in immune cells of older adults: a single-cell phenotypic analysis

Multi-Omics Integration Reveals Transcriptomic and Epigenetic Signatures Underlying Brain Structural Deficits in Major Depressive Disorder

Accelerated brain aging predicts impulsivity and symptom severity in depression

DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies

Association of aging related genes and immune microenvironment with major depressive disorder

Associations of DNA-Methylation Measures of Biological Aging With Social Disparities in Child and Adolescent Mental Health

Accelerated biological brain aging in major depressive disorder

Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives

Molecular and Genetic Characterization of Depression: Overlap with Other Psychiatric Disorders and Aging

Proteogenomic signature of risk of Alzheimer's disease and related dementia risk in individuals with a history of major depression disorder

Accelerated functional brain aging in major depressive disorder: evidence from a large scale fMRI analysis of Chinese participants

Lagged effects of childhood depressive symptoms on adult epigenetic aging

Epigenetic molecular underpinnings of brain structural-functional connectivity decoupling in patients with major depressive disorder